Hsbc Holdings PLC Has $85.11 Million Stock Holdings in Humana Inc. $HUM

Hsbc Holdings PLC increased its stake in shares of Humana Inc. (NYSE:HUM) by 9.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 330,794 shares of the insurance provider’s stock after acquiring an additional 27,530 shares during the quarter. Hsbc Holdings PLC’s holdings in Humana were worth $85,107,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Revolve Wealth Partners LLC acquired a new stake in Humana during the fourth quarter worth approximately $202,000. Woodline Partners LP grew its position in shares of Humana by 460.0% in the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after purchasing an additional 8,372 shares during the last quarter. Sivia Capital Partners LLC increased its stake in shares of Humana by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after purchasing an additional 452 shares during the period. Cresset Asset Management LLC increased its stake in shares of Humana by 10.3% during the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after purchasing an additional 222 shares during the period. Finally, WINTON GROUP Ltd lifted its holdings in Humana by 58.5% during the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after purchasing an additional 879 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Price Performance

Humana stock opened at $360.78 on Tuesday. The firm has a market cap of $43.32 billion, a PE ratio of 38.59, a price-to-earnings-growth ratio of 2.05 and a beta of 0.76. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The stock’s fifty day moving average price is $289.14 and its two-hundred day moving average price is $242.42. Humana Inc. has a one year low of $163.11 and a one year high of $380.86.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company’s revenue was up 23.5% compared to the same quarter last year. During the same period in the prior year, the company posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, research analysts expect that Humana Inc. will post 9.04 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.0%. Humana’s dividend payout ratio is currently 37.86%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on HUM shares. TD Cowen boosted their price target on Humana from $173.00 to $211.00 and gave the company a “hold” rating in a research note on Friday, May 1st. Piper Sandler reissued a “neutral” rating and set a $254.00 target price (up from $182.00) on shares of Humana in a report on Wednesday, May 13th. The Goldman Sachs Group upped their price target on shares of Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research note on Thursday, April 30th. William Blair initiated coverage on shares of Humana in a research report on Wednesday, May 20th. They set an “outperform” rating on the stock. Finally, UBS Group reiterated a “neutral” rating on shares of Humana in a research note on Monday, June 15th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $291.35.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.